loading
前日終値:
$8.88
開ける:
$8.97
24時間の取引高:
12,681
Relative Volume:
0.01
時価総額:
$1.23B
収益:
$175.51M
当期純損益:
$-78.02M
株価収益率:
-17.24
EPS:
-0.53
ネットキャッシュフロー:
$-34.18M
1週間 パフォーマンス:
+3.22%
1か月 パフォーマンス:
+16.67%
6か月 パフォーマンス:
+13.76%
1年 パフォーマンス:
+67.61%
1日の値動き範囲:
Value
$8.93
$9.365
1週間の範囲:
Value
$8.55
$9.365
52週間の値動き範囲:
Value
$5.195
$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Name
名前
Aurinia Pharmaceuticals Inc
Name
セクター
Healthcare (1166)
Name
電話
250-744-2487
Name
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
Name
職員
300
Name
Twitter
@AuriniaPharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
AUPH's Discussions on Twitter

AUPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AUPH
Aurinia Pharmaceuticals Inc
9.135 1.21B 175.51M -78.02M -34.18M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.27 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.31 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.53 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
569.10 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.27 29.19B 3.81B -644.79M -669.77M -6.24

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-11-04 ダウングレード Oppenheimer Outperform → Perform
2022-05-05 再開されました Cantor Fitzgerald Overweight
2021-12-10 アップグレード Oppenheimer Perform → Outperform
2021-10-28 ダウングレード Oppenheimer Outperform → Perform
2021-01-25 繰り返されました H.C. Wainwright Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-06-17 開始されました BTIG Research Buy
2020-05-05 開始されました Cowen Outperform
2020-01-10 開始されました Jefferies Buy
2019-12-16 繰り返されました H.C. Wainwright Buy
2018-03-16 繰り返されました Cantor Fitzgerald Overweight
2018-02-08 開始されました RBC Capital Mkts Outperform
2017-10-30 繰り返されました H.C. Wainwright Buy
2017-05-18 繰り返されました H.C. Wainwright Buy
2017-04-11 開始されました Cantor Fitzgerald Overweight
2017-03-22 繰り返されました FBR & Co. Outperform
2016-12-30 繰り返されました H.C. Wainwright Buy
2016-08-17 繰り返されました H.C. Wainwright Buy
2016-06-30 開始されました H.C. Wainwright Buy
2015-05-08 開始されました MLV & Co Buy
すべてを表示

Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース

pulisher
12:28 PM

What analysts say about Aurinia Pharmaceuticals Inc. stockFast-track wealth growth - Autocar Professional

12:28 PM
pulisher
Jul 22, 2025

What drives Aurinia Pharmaceuticals Inc. stock priceHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is Aurinia Pharmaceuticals Inc. a good long term investmentFree AI-Backed Trading Signals - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛

Jul 18, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Aurinia Pharmaceuticals Inc. stock price move sharplyDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aurinia Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Aurinia Pharmaceuticals Inc. stock attracts strong analyst attentionReal Trader Insights - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

How did AUPH's Q3 2024 earnings surprise impact short-term traders? - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Trading (AUPH) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 08, 2025

Wheat from chaff in BAFF: APRIL’s advent for Aurinia? - BioWorld MedTech

Jul 08, 2025
pulisher
Jul 07, 2025

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 06, 2025

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging For Aurinia Pharmaceuticals Stock Options - Barchart.com

Jul 02, 2025
pulisher
Jul 01, 2025

Leerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH) - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Aurinia’s aritinercept shows promising results in phase 1 study - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - New Castle News

Jun 30, 2025
pulisher
Jun 30, 2025

Aurinia Pharmaceuticals Inc.(NasdaqGM: AUPH) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

(AUPH) Trading Report - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 29, 2025

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025 - The Joplin Globe

Jun 29, 2025
pulisher
Jun 27, 2025

Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains? - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Aurinia shares rise ahead of key autoimmune therapy data - Proactive financial news

Jun 26, 2025
pulisher
Jun 21, 2025

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Jun 21, 2025
pulisher
Jun 15, 2025

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

Jun 15, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

California State Teachers Retirement System Sells 13,824 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by Bank of America Corp DE - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

As Edmonton biotech industry booms, Launa Aspeslet steps up to guide further success - Taproot Edmonton

Jun 10, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Buys New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 08, 2025

Aurinia Pharmaceuticals Inc (AUPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Aurinia Pharmaceuticals Inc (AUPH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Greenleaf Peter
Chief Executive Officer
Mar 03 '25
Sale
8.00
195,593
1,564,744
1,953,892
Greenleaf Peter
Chief Executive Officer
Mar 04 '25
Sale
7.92
164,947
1,306,380
1,788,945
Keenan Greg
Chief Medical Officer
Mar 03 '25
Sale
8.00
12,239
97,912
161,789
Miller Joseph M
Chief Financial Officer
Mar 03 '25
Sale
8.00
61,859
494,872
633,515
Miller Joseph M
Chief Financial Officer
Mar 04 '25
Sale
7.92
56,154
444,740
577,361
Robertson Stephen P.
EVP, General Counsel
Mar 03 '25
Sale
8.00
64,872
518,976
566,883
Robertson Stephen P.
EVP, General Counsel
Mar 04 '25
Sale
7.92
57,607
456,247
509,276
Donley Matthew Maxwell
Chief Operating Officer
Mar 03 '25
Sale
8.00
65,902
527,216
739,456
Donley Matthew Maxwell
Chief Operating Officer
Mar 04 '25
Sale
7.92
58,991
467,209
680,465
TANG KEVIN
Director
Mar 04 '25
Buy
7.96
748,038
5,953,304
10,029,500
$22.79
price up icon 4.47%
$35.94
price down icon 0.44%
$102.92
price down icon 0.07%
$27.60
price up icon 4.07%
$113.60
price up icon 1.92%
biotechnology ONC
$295.19
price down icon 0.15%
大文字化:     |  ボリューム (24 時間):